Abstract:The physiological role of alpha-synuclein (alpha-syn), an intrinsically disordered presynaptic neuronal protein, is believed to impact the release of neurotransmitters through interactions with the SNARE complex. However, under certain cellular conditions that are not well understood, alpha-syn will self-assemble into Beta-sheet rich fibrils that accumulate and form insoluble neuronal inclusions. Studies of patient derived brain tissues have concluded that these inclusions are associated with Parkinson's disease, the second most common neurodegenerative disorder, and other synuclein related diseases called synucleinopathies. In addition, repetitions of and specific mutations to the SNCA gene, the gene that encodes alpha-syn, results in an increased disposition for synucleinopathies. The latest advances in cryo-EM structure determination and real-space helical reconstruction methods have resulted in over 60 in vitro structures of alpha-syn fibrils solved to date, with a handful of these reaching a resolution below 2.5 Angstrom. Here, we provide a protocol for alpha-syn protein expression, purification, and fibrilization. We detail how sample quality is assessed by negative stain transmission electron microscopy (NS-TEM) analysis and followed by sample vitrification using the Vitrobot Mark IV vitrification robot. We provide a detailed step by step protocol for high resolution cryo-EM structure determination of alpha-syn fibrils using RELION and a series of specialized helical reconstruction tools that can be run within RELION. Finally, we detail how ChimeraX, Coot, and Phenix are used to build and refine a molecular model into the high resolution cryo-EM map. This workflow resulted in a 2.04 Angstrom structure of alpha-syn fibrils with excellent resolution of residues 36 to 97 and an additional island of density for residues 15 to 22 that had not been previously reported. This workflow should serve as a starting point for individuals new to the neurodegeneration and structural biology fields. Together, this procedure lays the foundation for advanced structural studies of alpha-synuclein and other amyloid fibrils.

Emerging Trends in Cryo-EM-based Structural Studies of Neuropathological Amyloids

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Cryo-EM structures of pathogenic fibrils and their impact on neurodegenerative disease research

CryoET of β-amyloid and tau within postmortem Alzheimer's disease brain

Reconstitution of the Alzheimer’s Disease Tau Core Structure from Recombinant Tau297–391 Yields Variable Quaternary Structures as Seen by Negative Stain and Cryo-EM

Cryo‐EM structures of tau filaments from SH‐SY5Y cells seeded with brain extracts from cases of Alzheimer's disease and corticobasal degeneration

High-Resolution Cryo-EM Structure Determination of α-Synuclein – A Prototypical Amyloid Fibril

Structural Identification of Individual Helical Amyloid Filaments by Integration of Cryo-Electron Microscopy-Derived Maps in Comparative Morphometric Atomic Force Microscopy Image Analysis

Cryo-EM Structures Reveal Tau Filaments from Down Syndrome Adopt Alzheimer's Disease Fold

Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue

Structural architecture of amyloid-β oligomers, curvilinear protofibrils and annular assemblies, imaged by cryo-EM and cryo-ET

Cryo-EM observation of the amyloid key structure of polymorphic TDP-43 amyloid fibrils

Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics

Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Cryo‐electron Microscopy Imaging of Alzheimer's Amyloid‐beta 42 Oligomer Displayed on a Functionally and Structurally Relevant Scaffold

New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy

Cryo-EM structure of alpha-synuclein fibrils amplified by PMCA from PD and MSA patient brains

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer’s Disease, Parkinson’s Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

The structural line between prion and "prion-like": Insights from prion protein and tau